HealthEast Medical Research Institute

Saint Paul, Minnesota 55104

0 studies enrolling now · 9 studies all time

What they study most

Acute Coronary Syndrome, Aortic Valve Stenosis, Atrial Fibrillation, Cardiovascular Disease, Coronary Heart Disease (CHD), Dyslipidemia, Heart Failure, Hyperlipidemia, Myocardial Infarction, Type2 Diabetes

Studies at this site

• A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome — Completed
• Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke — Completed
• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early
• Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD) — Running, not enrolling
• Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF) — Completed
• INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure — Completed
• Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients — Completed
• Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events — Completed
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early